PubRank

A S Luyckx

Author PubWeight™ 48.76‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Glucagon secretion in diabetic patients with idiopathic haemochromatosis. Diabetologia 1977 1.42
2 Presence of pancreatic glucagon in the portal plasma of human neonates. Differences in the insulin and glucagon responses to glucose between normal infants and infants from diabetic mothers. Diabetologia 1972 1.15
3 Diuretic activity of torasemide and furosemide in chronic heart failure: a comparative double blind cross-over study. Eur J Clin Pharmacol 1986 1.05
4 Factors controlling gastric-glucagon release. J Clin Invest 1977 1.02
5 Arguments for a regulation of pancreatic glucagon secretion by circulating plasma free fatty acids. Proc Soc Exp Biol Med 1970 0.98
6 A 6-hour nocturnal interruption of a continuous subcutaneous insulin infusion: 1. Metabolic and hormonal consequences and scheme for a prompt return to adequate control. Diabetologia 1983 0.98
7 Carbohydrate metabolism in women who used oral contraceptives containing levonorgestrel or desogestrel: a 6-month prospective study. Fertil Steril 1986 0.96
8 Growth hormone, cortisol, and glucagon concentrations during plasma free fatty acid depression: different effects of nicotinic acid and an adenosine derivative (BM 11.189). J Clin Endocrinol Metab 1983 0.93
9 Mechanisms involved in the exercise-induced increase in glucagon secretion in rats. Diabetes 1974 0.92
10 Plasma glucagon levels in normal women during pregnancy. Diabetologia 1975 0.90
11 Catecholamines and exercise-induced glucagon and fatty acid mobilization in the rat. Am J Physiol 1975 0.89
12 Letter: Potentiation of hypoglycemic effect of sulfonylureas by clofibrate. N Engl J Med 1976 0.88
13 Glucagon and diabetes: a reappraisal. Diabetologia 1979 0.88
14 Effect of acute kidney exclusion by ligation of renal arteries on peripheral plasma glucagon levels and pancreatic glucagon production in the anesthetized dog. Metabolism 1975 0.88
15 Metabolic alterations after a two-hour nocturnal interruption of a continuous subcutaneous insulin infusion. Diabetes Care 1984 0.87
16 Glucose and insulin in the regulation of glucagon release from the isolated perfused dog stomach. Endocrinology 1978 0.87
17 Renal handling of endogenous glucagon in the dog: comparison with insulin. Metabolism 1974 0.86
18 Effect of dog jejunum "glucagon-like immunoreactive material" on adipose tissue metabolism. Horm Metab Res 1969 0.86
19 Metabolic adaptations in post-exercise recovery. Clin Physiol 1982 0.84
20 Biological properties of a transplantable islet-cell tumor of the golden hamster. II. Insulin content of the tumor and some metabolic characteristics of the tumor-bearing animals. Diabetes 1967 0.84
21 A 6-hour nocturnal interruption of a continuous subcutaneous insulin infusion: 2. Marked attenuation of the metabolic deterioration by somatostatin. Diabetologia 1983 0.84
22 Fate of exogenous glucose during exercise of different intensities in humans. J Appl Physiol Respir Environ Exerc Physiol 1982 0.83
23 Plasma glucagon after kidney exclusion: experiments in somatostatin-infused and in eviscerated dogs. Metabolism 1976 0.83
24 Muscular exercise and pancreatic function in rats. Isr J Med Sci 1972 0.83
25 Effect of oleic acid on insulin secretion by the isolated perfused rat pancreas. Diabetologia 1979 0.82
26 Similar metabolic effects of pulsatile versus continuous human insulin delivery during euglycemic, hyperinsulinemic glucose clamp in normal man. Diabetes 1984 0.82
27 Stimulation of insulin secretion after prostaglandin PGE 1 in the anesthetized dog. Biochem Pharmacol 1973 0.82
28 [Stimulation by carbamylcholine of dog gastric-glucagon release (author's transl) (proceedings)]. Ann Endocrinol (Paris) 1979 0.82
29 Angioplastic necrolytic migratory erythema. Unique association of necrolytic migratory erythema, extensive angioplasia, and high molecular weight glucagon-like polypeptide. Am J Dermatopathol 1982 0.81
30 Metabolic adaptation to prolonged exercise in severely obese subjects. Int J Obes 1983 0.80
31 Independance of glucagon and insulin handling by the isolated perfused dog kidney. Diabetologia 1976 0.80
32 Insulin oscillations per se do not affect glucose turnover parameters in normal man. J Clin Endocrinol Metab 1986 0.80
33 Lipids and lipoproteins in chronic uraemia. A study of the influence of regular haemodialysis. Eur J Clin Invest 1976 0.80
34 Hormonal and metabolic adaptation to protein-supplemented fasting in obese subjects. Int J Obes 1982 0.79
35 Effect of insulin on glucagon enhanced lipolysis in vitro. Diabetologia 1969 0.79
36 Cardiovascular effects of intravenous tolmesoxide in hypertensive patients. Arch Int Pharmacodyn Ther 1981 0.79
37 Pituitary-testicular axis in diabetic men with and without sexual impotence. Diabete Metab 1978 0.78
38 Influence of metformin on arginine-induced glucagon secretion in human diabetes. Diabete Metab 1975 0.78
39 Pharmacological compounds affecting plasma glucagon levels in rats. Biochem Pharmacol 1976 0.78
40 Effect of ouabain on insulin secretion in the anesthetized dog. Biochem Pharmacol 1972 0.78
41 Vagal stimulation and its role in eliciting gastrin but not glucagon release from the isolated perfused dog stomach. Gut 1978 0.78
42 Inhibition by somatostatin of carbamylcholine-induced gastrin and glucagon release from the isolated perfused canine stomach. Gut 1981 0.78
43 Interrelationships glucagon-adrenergic system in experimental and clinical conditions. Arch Int Pharmacodyn Ther 1968 0.78
44 Effect of L8027, a new potent inhibitor of prostaglandin biosynthesis, on the metabolism and response to glucagon of rat adipose tissue. Biochem Pharmacol 1974 0.78
45 Pulsatile hyperglucagonemia fails to increase hepatic glucose production in normal man. Am J Physiol 1987 0.77
46 Possible role of endogenous prostaglandins in glucagon secretion by isolated guinea-pig islets. Diabetologia 1978 0.77
47 The breakfast tolerance test: a return to physiology. Diabete Metab 1976 0.77
48 Metabolism of hydroxyethylrutosides (HR): metabolism of [14C]-HR in man. Arzneimittelforschung 1976 0.77
49 Influence of elevated plasma free fatty acids on the glucagon response to hypoglycemia in normal and in pregnant women. Metabolism 1978 0.77
50 Availability of glucose given orally during exercise. J Appl Physiol Respir Environ Exerc Physiol 1984 0.77
51 Effect of physical training on utilization of a glucose load given orally during exercise. Am J Physiol 1984 0.77
52 Glibenclamide pharmacokinetics in acarbose-treated type 2 diabetics. Eur J Clin Pharmacol 1984 0.76
53 Studies on the pathogenesis of reactive hypoglycemia: role of insulin and glucagon. Horm Metab Res 1976 0.76
54 Utilization of oral sucrose load during exercise in humans. Effect of the alpha-glucosidase inhibitor acarbose. Diabetes 1986 0.76
55 Effects of acetylsalicylic acid on blood glucose, plasma FFA, glycerol, 3-hydroxybutyrate, alanine, C-peptide, glucagon and growth hormone responses to arginine in insulin-dependent diabetics. Diabete Metab 1980 0.76
56 Influence of ketone body infusion on plasma growth hormone and glucagon in man. J Clin Endocrinol Metab 1983 0.76
57 Acarbose in reactive hypoglycemia: a double-blind study. Int J Clin Pharmacol Ther Toxicol 1984 0.76
58 Remarkable metabolic availability of oral glucose during long-duration exercise in humans. J Appl Physiol (1985) 1986 0.75
59 Improvement of metabolic control in insulin dependent diabetics treated with the alpha-glucosidase inhibitor acarbose for two months. Diabetologia 1981 0.75
60 Glipizide increases plasma insulin but not C-peptide level after a standardized breakfast in type 2 diabetic patients. Eur J Clin Pharmacol 1984 0.75
61 [Chronobiology in endocrinology]. Rev Med Liege 1985 0.75
62 Insulin-stimulated glucose disposal is not increased in anorexia nervosa. J Clin Endocrinol Metab 1985 0.75
63 Studies on the hyperglycemic effect of diphenylhydantoin in normal golden hamsters. Horm Metab Res 1976 0.75
64 Effect of somatostatin on metabolic and hormonal changes induced by nicotinic acid in insulin-dependent diabetics. Diabetologia 1976 0.75
65 [Metabolic and hormonal response to a standardized breakfast in type 2 diabetes. Effect of glipizide]. Rev Med Liege 1983 0.75
66 [Syndrome of reactive hypoglycemia. Myth or reality]. Journ Annu Diabetol Hotel Dieu 1983 0.75
67 Effect of various concentrations of calcium on arginine-induced insulin and glucagon release in vitro. Rev Esp Fisiol 1978 0.75
68 Blood collection while using a continuous glucose analyzer without insertion of an additional venous catheter. Diabetologia 1983 0.75
69 Effect of somatostatin in the Syrian hamster bearing a transplantable islet-cell tumor. Horm Metab Res 1978 0.75
70 [Chronopharmacology and chronotherapeutics]. Rev Med Liege 1985 0.75
71 Effect of oleic and octanoic acids on glucagon and insulin secretion in vitro. Horm Metab Res 1982 0.75
72 Adipose tissue lipolysis in golden hamsters with chronic hypoglycemia and hyperinsulinemia due to a transplantable islet cell tumor. Horm Metab Res 1970 0.75
73 Glucose utilization during exercise in normal and diabetic subjects. The role of insulin. Diabetes 1981 0.75
74 [Hemoglobin A1c and diabetes control (author's transl)]. Diabete Metab 1979 0.75
75 Glucagon and gastrin release by the isolated perfused dog stomach in response to arginine. Metabolism 1976 0.75
76 Effect of phosphate on the arginine-induced insulin release by the isolated perfused rat pancreas. Adv Exp Med Biol 1980 0.75
77 [Endogenous glucagon and liver glucose balance in the anesthetized dog (author's transl) (proceedings)]. Ann Endocrinol (Paris) 1979 0.75
78 Effect of bicarbonate on the arginine-induced insulin and glucagon secretion in vitro. Horm Metab Res 1981 0.75
79 Lack of systematic metabolic alterations after a one-hour interruption of continuous subcutaneous insulin infusion in type I diabetic patients. Diabetes Care 1986 0.75
80 Plasma glucagon and clinical control of maturity-onset type diabetes. Effects of diet, placebo and glipizide. Diabete Metab 1977 0.75
81 Plasma C-peptide response to arginine in insulin-dependent diabetic subjects. J Endocrinol Invest 1980 0.75
82 Pharmacokinetics and pharmacological properties of two galenical preparations of glibenclamide, HB419 and HB420, in non insulin-dependent (type 2) diabetes. Int J Clin Pharmacol Ther Toxicol 1987 0.75
83 Endogenous prostaglandins modulate glucagon secretion by isolated guinea-pig islets. Adv Prostaglandin Thromboxane Res 1980 0.75
84 Effect of phosphate omission on arginine-induced insulin and glucagon release by the isolated perfused rat pancreas. FEBS Lett 1977 0.75
85 Circadian profiles of blood glucose and plasma free insulin during treatment with semisynthetic and biosynthetic human insulin, and comparison with conventional monocomponent preparations. Eur J Clin Pharmacol 1983 0.75
86 Neurotransmitters and glucagon release from the isolated, perfused canine stomach. Diabetes 1980 0.75
87 Hypercholesterolaemia type II: changes in plasma insulin and glucagon levels after portacaval shunt. J Inherit Metab Dis 1980 0.75
88 Failure of indomethacin to affect arginine-induced C-peptide and glucagon release in insulin-treated diabetics. Major role of residual B cell function in conditioning the magnitude of the blood glucose rise after intravenous arginine. Diabetologia 1981 0.75
89 Plasma insulin in reactive hypoglycemia. Diabetes 1971 0.75
90 Effect of indomethacin on the metabolic and hormonal response to a standardized breakfast in normal subjects. Acta Diabetol Lat 1982 0.75
91 [The glucagonomas (author's transl)]. Diabete Metab 1981 0.75
92 B-cell response to a standardized breakfast in end-stage renal failure. Acta Diabetol Lat 1985 0.75
93 Metabolic availability of carbohydrates ingested during, before, or after muscular exercise. Diabetes Metab Rev 1986 0.75
94 [Treatment of arterial hypertension in the diabetic]. Rev Med Liege 1982 0.75
95 [What the physician should know about lactic acidosis and biguanides]. Brux Med 1978 0.75
96 [Postaglandins and pancreatic hormones]. Journ Annu Diabetol Hotel Dieu 1981 0.75
97 Gastric-glucagon: physiology and pathology. Adv Exp Med Biol 1978 0.75
98 Immunogenicity of semisynthetic human insulin in man. Long-term comparison with porcine monocomponent insulin. Acta Diabetol Lat 1986 0.75
99 Effect of oleic acid on arginine-induced glucagon secretion by the isolated perfused rat pancreas. Acta Diabetol Lat 1980 0.75
100 Renal control of cephalic and intestinal removal of glucagon in the anesthetized dog. Horm Metab Res 1984 0.75
101 Influence of metabolic substrates on the secretion of glucagon and insulin by the isolated perfused rat pancreas. Isr J Med Sci 1972 0.75
102 [Metabolic consequences of insulin deficiency]. Journ Annu Diabetol Hotel Dieu 1984 0.75
103 Effect of glucose on plasma glucagon and free fatty acids during prolonged exercise. Eur J Appl Physiol Occup Physiol 1978 0.75
104 Relationship between plasma free fatty acid levels and human placental lactogen secretion in late pregnancy. J Clin Endocrinol Metab 1977 0.75
105 [Extrapancreatic glucagon: experimental findings and clinical significance]. Journ Annu Diabetol Hotel Dieu 1978 0.75
106 [Importance of the artificial pancreas in the therapeutic approach to insulin-dependent diabetes and in the diagnosis of organic hypoglycemia]. Rev Med Liege 1982 0.75
107 Stimulation of gastric-glucagon release by prostaglandin E1. Prostaglandins Med 1978 0.75
108 Glucagon secretion by the transplantable islet-cell tumor of the Syrian hamster. Horm Metab Res 1976 0.75
109 Scopion venom-induced release of noradrenalin does not modify glucagon-output from the isolated perfused dog stomach. Horm Metab Res 1978 0.75
110 Hormonal and metabolic changes induced by elevated plasma free fatty acids in term pregnancy. I. Effect on maternal blood glucose, insulin and human placental lactogen circulating levels. J Clin Endocrinol Metab 1975 0.75
111 Effect of physical training on the oxidation of an oral glucose load at rest: a naturally labeled 13C-glucose study. Diabete Metab 1983 0.75
112 Growth hormone, glucagon, and insulin response to depression of plasma free fatty acids and the effect of glucose infusion. J Clin Endocrinol Metab 1977 0.75
113 Furosemide intravenous infusion in normal man: electrolytic, metabolic and hormonal effects. Lack of changes in basal insulin and glucagon plasma levels. Arch Int Pharmacodyn Ther 1980 0.75
114 Computer-assisted instruction for diabetics. An original project developed at the University of Liège, Belgium. Diabete Metab 1981 0.75
115 Effect of protein-supplemented fasting on the fuel-hormone response to prolonged exercise in obese subjects. Int J Obes 1983 0.75
116 Insulin, prostaglandin E2 and glucagon release by human tissue incubated in vitro. Influence of indomethacin. Diabete Metab 1981 0.75
117 [Extrapancreatic glucagon in the dog (author's transl)]. Ann Endocrinol (Paris) 1980 0.75
118 Pancreatic B-cell response to a test-meal in lean and obese diabetic patients: relation to metabolic control. Acta Diabetol Lat 1981 0.75
119 [Role of the liver in endogenous glucagon-uptake in the anesthetized dog (author's transl) (proceedings)]. Ann Endocrinol (Paris) 1979 0.75